Largest Drug Manufacturers - Specialty & Generic Companies by Market Cap
The Drug Manufacturers - Specialty & Generic sector has 629 publicly listed stocks with a combined market cap of $1.15 Trillion. Takeda Pharmaceutical Co Ltd ADR leads the sector with a market cap of $52.60 Billion. This ranking covers all Drug Manufacturers - Specialty & Generic stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
$52.60 Billion | $52.60 Billion | USA | $16.65 | +0.30% | -6.72% | 71.71 Million |
| 2 |
GALDERMA GROUP AG
NYSE:GALDY |
$44.32 Billion | $44.32 Billion | USA | $38.01 | +0.66% | -5.71% | 2.21 Million |
| 3 |
Takeda Pharmaceutical Company Limited
F:TKDA |
$43.60 Billion | €37.29 Billion | Germany | €15.60 | +1.30% | -0.64% | 4.80K |
| 4 |
Haleon plc
NYSE:HLN |
$41.35 Billion | $41.35 Billion | USA | $9.39 | +2.18% | -4.77% | 245.76 Million |
| 5 |
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
$40.28 Billion | CN¥275.25 Billion | China | CN¥43.15 | +1.12% | -6.24% | 1.89 Billion |
| 6 |
Galderma Group N
SW:GALD |
$37.01 Billion | CHF29.28 Billion | Switzerland | CHF155.60 | +0.42% | -1.92% | 9.60 Million |
| 7 |
Teva Pharmaceutical Industries Limited
F:TEV |
$34.58 Billion | €29.58 Billion | Germany | €28.60 | +4.00% | +9.58% | 27.27K |
| 8 |
Zoetis Inc
NYSE:ZTS |
$32.47 Billion | $32.47 Billion | USA | $73.67 | +0.96% | -3.43% | 112.33 Million |
| 9 |
Sandoz Group AG
SW:SDZ |
$28.58 Billion | CHF22.61 Billion | Switzerland | CHF66.50 | -0.36% | -2.72% | 21.08 Million |
| 10 |
HANSOH PHARMAC. HD-00001
F:3KY |
$22.06 Billion | €18.87 Billion | Germany | €3.74 | +5.50% | -4.93% | 3.66K |
| 11 |
United Therapeutics Corporation
NASDAQ:UTHR |
$21.42 Billion | $21.42 Billion | USA | $502.70 | +1.12% | +2.54% | 11.52 Million |
| 12 |
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
$20.43 Billion | Rs1.89 Trillion | India | Rs4965.50 | +0.72% | +1.22% | 7.02 Million |
| 13 |
Merck KGaA
XETRA:MRK |
$19.73 Billion | €16.87 Billion | Germany | €130.55 | -0.68% | -3.90% | 5.29 Million |
| 14 |
Viatris Inc
NASDAQ:VTRS |
$18.70 Billion | $18.70 Billion | USA | $16.66 | +0.91% | -2.52% | 190.45 Million |
| 15 |
MERCK KGAA NAM.SP.ADR
F:MRKC |
$17.07 Billion | €14.60 Billion | Germany | €22.60 | -2.59% | -1.74% | 1.20K |
| 16 |
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
$16.68 Billion | Skr155.01 Billion | Sweden | Skr448.20 | +2.24% | -1.45% | 6.08 Million |
| 17 |
Yunnan Baiyao Group Co Ltd
SHE:000538 |
$13.25 Billion | CN¥90.57 Billion | China | CN¥50.76 | +0.71% | -0.51% | 177.26 Million |
| 18 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
$13.03 Billion | $13.03 Billion | USA | $157.22 | +0.64% | -0.71% | 26.13 Million |
| 19 |
IPSEN SA SP.ADR 1/4/ EO 1
F:I7G0 |
$12.92 Billion | €11.05 Billion | Germany | €40.80 | +3.03% | +0.00% | 3.43K |
| 20 |
Zydus Lifesciences Limited
NSE:ZYDUSLIFE |
$12.18 Billion | Rs1.13 Trillion | India | Rs1119.10 | +0.12% | -2.09% | 41.73 Million |
| 21 |
Zhejiang Nhu Co Ltd
SHE:002001 |
$12.11 Billion | CN¥82.74 Billion | China | CN¥26.92 | +1.55% | +0.22% | 775.98 Million |
| 22 |
Cipla Limited
NSE:CIPLA |
$11.93 Billion | Rs1.10 Trillion | India | Rs1366.00 | -0.53% | -2.06% | 18.46 Million |
| 23 |
Laurus Labs Limited
NSE:LAURUSLABS |
$11.50 Billion | Rs1.06 Trillion | India | Rs1969.00 | +1.23% | +5.38% | 76.18 Million |
| 24 |
Dr. Reddy’s Laboratories Ltd ADR
NYSE:RDY |
$11.16 Billion | $11.16 Billion | USA | $13.58 | +5.76% | +4.95% | 58.86 Million |
| 25 |
Elanco Animal Health
NYSE:ELAN |
$11.05 Billion | $11.05 Billion | USA | $23.15 | -0.09% | -5.20% | 115.88 Million |
| 26 |
Ipsen SA
PA:IPN |
$10.50 Billion | €8.98 Billion | France | €159.10 | +1.27% | -3.40% | 1.90 Million |
| 27 |
Aurobindo Pharma Limited
NSE:AUROPHARMA |
$10.45 Billion | Rs966.52 Billion | India | Rs1679.80 | +0.68% | +2.60% | 19.14 Million |
| 28 |
Lupin Limited
NSE:LUPIN |
$10.36 Billion | Rs957.91 Billion | India | Rs2095.00 | +0.83% | -1.74% | 18.14 Million |
| 29 |
Mankind Pharma Ltd
NSE:MANKIND |
$10.18 Billion | Rs941.74 Billion | India | Rs2280.00 | +1.86% | -3.75% | 7.89 Million |
| 30 |
Krka d. d
WAR:KRK |
$9.35 Billion | zł33.97 Billion | Poland | zł1122.00 | -0.88% | -1.58% | 2.38K |
| 31 |
Dr. Reddy's Laboratories Limited
F:RDDA |
$9.23 Billion | €7.89 Billion | Germany | €10.10 | -0.98% | -0.98% | 2.60K |
| 32 |
Alkermes Plc
NASDAQ:ALKS |
$7.69 Billion | $7.69 Billion | USA | $45.83 | -0.30% | -2.24% | 31.00 Million |
| 33 |
Shanghai Fosun Pharmaceutical Group Co Ltd
SHG:600196 |
$6.80 Billion | CN¥46.50 Billion | China | CN¥21.95 | +1.62% | -1.75% | 631.94 Million |
| 34 |
Huadong Medicine Co Ltd
SHE:000963 |
$6.79 Billion | CN¥46.41 Billion | China | CN¥26.46 | +0.76% | -3.32% | 509.76 Million |
| 35 |
Alkermes plc
F:8AK |
$6.65 Billion | €5.69 Billion | Germany | €39.46 | -0.03% | -1.10% | 0.00 |
| 36 |
Alkem Laboratories Limited
NSE:ALKEM |
$6.58 Billion | Rs608.29 Billion | India | Rs5087.50 | -0.98% | -2.03% | 3.27 Million |
| 37 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
$6.56 Billion | €5.61 Billion | Germany | €34.12 | -1.27% | -2.79% | 3.90K |
| 38 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ:AMRX |
$5.96 Billion | $5.96 Billion | USA | $17.22 | +1.23% | -3.64% | 40.24 Million |
| 39 |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
$5.92 Billion | CN¥40.44 Billion | China | CN¥24.30 | +1.72% | -2.41% | 221.18 Million |
| 40 |
Abbott India Limited
NSE:ABBOTINDIA |
$5.87 Billion | Rs542.92 Billion | India | Rs25550.00 | +1.15% | -1.52% | 191.26K |
| 41 |
Liquidia Technologies Inc
NASDAQ:LQDA |
$5.85 Billion | $5.85 Billion | USA | $65.31 | -2.15% | -4.84% | 35.30 Million |
| 42 |
H Lundbeck A/S
CO:HLUN-B |
$5.54 Billion | Dkr35.42 Billion | Denmark | Dkr44.66 | +0.54% | +1.22% | 15.46 Million |
| 43 |
Gland Pharma Limited
NSE:GLAND |
$5.21 Billion | Rs482.06 Billion | India | Rs2922.30 | -0.83% | +0.50% | 22.72 Million |
| 44 |
Shenzhen Salubris Pharmaceuticals Co Ltd
SHE:002294 |
$4.93 Billion | CN¥33.72 Billion | China | CN¥30.25 | +0.60% | -3.72% | 405.32 Million |
| 45 |
Lantheus Holdings Inc
NASDAQ:LNTH |
$4.93 Billion | $4.93 Billion | USA | $100.32 | +0.07% | -0.65% | 28.69 Million |
| 46 |
Ajanta Pharma Limited
NSE:AJANTPHARM |
$4.77 Billion | Rs441.45 Billion | India | Rs3533.40 | +0.38% | +0.35% | 1.82 Million |
| 47 |
Beijing Tongrentang Co Ltd
SHG:600085 |
$4.73 Billion | CN¥32.33 Billion | China | CN¥23.57 | +0.73% | -2.36% | 132.17 Million |
| 48 |
Humanwell Healthcare Group Co Ltd
SHG:600079 |
$4.43 Billion | CN¥30.26 Billion | China | CN¥18.54 | +1.15% | -1.01% | 204.06 Million |
| 49 |
Suven Pharmaceuticals Limited
NSE:SUVENPHAR |
$4.40 Billion | Rs406.97 Billion | India | Rs1063.80 | +0.00% | +0.00% | 191.99K |
| 50 |
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
$4.38 Billion | CN¥29.93 Billion | China | CN¥46.47 | +1.37% | -4.28% | 139.66 Million |
| 51 |
Changchun High & New Technology Industries Group Inc
SHE:000661 |
$4.31 Billion | CN¥29.48 Billion | China | CN¥72.26 | +1.12% | -2.01% | 166.12 Million |
| 52 |
JB Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM |
$4.18 Billion | Rs386.77 Billion | India | Rs2408.90 | -3.87% | -1.10% | 13.52 Million |
| 53 |
Hanmi Pharm Co Ltd
KO:128940 |
$4.07 Billion | ₩6.01 Trillion | Korea | ₩474000.00 | +2.16% | +0.11% | 4.25 Million |
| 54 |
Emcure Pharmaceuticals Ltd
NSE:EMCURE |
$4.06 Billion | Rs375.18 Billion | India | Rs1978.90 | +0.82% | +6.70% | 3.12 Million |
| 55 |
Yuhan Corp.
KO:000100 |
$3.95 Billion | ₩5.82 Trillion | Korea | ₩79100.00 | -0.38% | -2.83% | 6.92 Million |
| 56 |
Indivior PLC Ordinary Shares
NASDAQ:INDV |
$3.91 Billion | $3.91 Billion | USA | $34.47 | -0.06% | -1.03% | 41.74 Million |
| 57 |
Apeloa Pharmaceutical Co Ltd
SHE:000739 |
$3.84 Billion | CN¥26.27 Billion | China | CN¥22.68 | +3.37% | +1.48% | 558.97 Million |
| 58 |
Wockhardt Limited
NSE:WOCKPHARMA |
$3.83 Billion | Rs354.14 Billion | India | Rs2179.40 | -1.86% | +11.73% | 24.16 Million |
| 59 |
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
$3.76 Billion | CN¥25.70 Billion | China | CN¥15.38 | +1.25% | -3.09% | 493.12 Million |
| 60 |
Aspen Pharmacare Holdings Ltd
JSE:APN |
$3.75 Billion | ZAC7.06 Trillion | South Africa | ZAC15898.00 | +1.26% | +5.68% | 39.95 Million |
| 61 |
Siegfried Holding Ltd
SW:SFZN |
$3.71 Billion | CHF2.94 Billion | Switzerland | CHF73.15 | +3.54% | +3.76% | 3.16 Million |
| 62 |
Hims Hers Health Inc
NYSE:HIMS |
$3.71 Billion | $3.71 Billion | USA | $28.81 | +4.73% | +3.56% | 274.92 Million |
| 63 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA |
$3.70 Billion | $3.70 Billion | USA | $76.58 | +0.41% | -4.83% | 11.26 Million |
| 64 |
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX |
$3.58 Billion | $3.58 Billion | USA | $33.64 | +6.39% | -0.94% | 80.24 Million |
| 65 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX |
$3.57 Billion | $3.57 Billion | USA | $12.18 | +2.01% | -2.72% | 43.40 Million |
| 66 |
INDIVIOR PLC DL 050
F:2IVB |
$3.51 Billion | €3.01 Billion | Germany | €27.00 | -1.53% | -0.74% | 1.51K |
| 67 |
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
$3.43 Billion | CN¥23.42 Billion | China | CN¥25.41 | +2.46% | -1.28% | 138.70 Million |
| 68 |
Laboratorios Farmaceuticos ROVI
MC:ROVI |
$3.43 Billion | €2.93 Billion | Spain | €57.30 | -0.09% | -3.37% | 2.36 Million |
| 69 |
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
$3.42 Billion | CN¥23.39 Billion | China | CN¥15.62 | +1.63% | -2.31% | 699.22 Million |
| 70 |
Neuland Laboratories Limited
NSE:NEULANDLAB |
$3.27 Billion | Rs301.95 Billion | India | Rs23535.00 | -1.11% | +2.82% | 1.22 Million |
| 71 |
Hypera S.A
SA:HYPE3 |
$3.25 Billion | R$16.57 Billion | Brazil | R$23.53 | +3.38% | +3.52% | 76.21 Million |
| 72 |
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
$3.23 Billion | CN¥22.07 Billion | China | CN¥21.79 | +1.63% | -3.41% | 227.54 Million |
| 73 |
SIMCERE PHARMAC. GRP LTD
F:S2P |
$3.17 Billion | €2.72 Billion | Germany | €1.23 | +1.65% | -8.89% | 1.87K |
| 74 |
Walvax BioTech
SHE:300142 |
$3.13 Billion | CN¥21.42 Billion | China | CN¥13.39 | +2.29% | +3.16% | 3.26 Billion |
| 75 |
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
$3.10 Billion | CN¥21.15 Billion | China | CN¥24.89 | +6.41% | +1.01% | 674.86 Million |
| 76 |
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623 |
$3.08 Billion | CN¥21.02 Billion | China | CN¥17.58 | -0.40% | -4.92% | 287.75 Million |
| 77 |
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
$3.06 Billion | CN¥20.93 Billion | China | CN¥14.01 | -0.07% | -4.89% | 341.08 Million |
| 78 |
Hybio Pharmaceutical
SHE:300199 |
$3.04 Billion | CN¥20.77 Billion | China | CN¥23.51 | +3.25% | +3.02% | 1.03 Billion |
| 79 |
Piramal Pharma Limited
NSE:PPLPHARMA |
$3.03 Billion | Rs279.98 Billion | India | Rs211.35 | -0.54% | -1.46% | 108.63 Million |
| 80 |
ASPEN PHAR.UN.ADR /1 O.N.
F:LDZU |
$2.95 Billion | €2.52 Billion | Germany | €6.90 | +4.55% | +0.73% | 240.00 |
| 81 |
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
$2.89 Billion | CN¥19.74 Billion | China | CN¥34.63 | +0.29% | -3.70% | 55.01 Million |
| 82 |
Betta Pharmaceuticals Co Ltd
SHE:300558 |
$2.88 Billion | CN¥19.67 Billion | China | CN¥46.74 | +2.59% | -4.57% | 379.03 Million |
| 83 |
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
$2.80 Billion | CN¥19.15 Billion | China | CN¥90.29 | +3.45% | +1.64% | 123.09 Million |
| 84 |
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
$2.77 Billion | CN¥18.95 Billion | China | CN¥1.37 | -0.72% | -0.72% | 4.39 Billion |
| 85 |
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
$2.69 Billion | CN¥18.39 Billion | China | CN¥7.30 | +4.43% | -6.17% | 9.23 Billion |
| 86 |
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
$2.68 Billion | $2.68 Billion | USA | $5.74 | +1.77% | -9.03% | 4.32 Million |
| 87 |
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
$2.58 Billion | CN¥17.65 Billion | China | CN¥19.16 | +0.79% | -5.62% | 164.03 Million |
| 88 |
Almirall S.A.
MC:ALM |
$2.57 Billion | €2.20 Billion | Spain | €10.26 | +0.59% | -1.54% | 3.08 Million |
| 89 |
Curaleaf Holdings Inc.
TO:CURA |
$2.52 Billion | CA$3.49 Billion | Canada | CA$14.05 | +5.72% | +6.60% | 5.03 Million |
| 90 |
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380 |
$2.50 Billion | CN¥17.07 Billion | China | CN¥9.33 | +0.97% | +1.86% | 435.32 Million |
| 91 |
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
$2.44 Billion | CN¥16.67 Billion | China | CN¥16.05 | +1.39% | +0.19% | 173.61 Million |
| 92 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN |
$2.41 Billion | $2.41 Billion | USA | $41.49 | -0.36% | -5.64% | 13.65 Million |
| 93 |
Livzon Pharmaceutical Group Inc
SHE:000513 |
$2.32 Billion | CN¥15.88 Billion | China | CN¥27.00 | +1.43% | +0.86% | 179.17 Million |
| 94 |
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
$2.26 Billion | CN¥15.42 Billion | China | CN¥14.62 | +1.11% | -1.55% | 148.87 Million |
| 95 |
Prestige Brand Holdings Inc
NYSE:PBH |
$2.26 Billion | $2.26 Billion | USA | $47.62 | +1.43% | -9.40% | 10.46 Million |
| 96 |
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
$2.25 Billion | CN¥15.36 Billion | China | CN¥34.00 | +1.01% | -4.47% | 244.40 Million |
| 97 |
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
$2.24 Billion | CN¥15.30 Billion | China | CN¥7.81 | +0.77% | -2.62% | 593.52 Million |
| 98 |
Bausch Health Companies Inc
TO:BHC |
$2.23 Billion | CA$3.09 Billion | Canada | CA$8.25 | +1.85% | -11.48% | 16.48 Million |
| 99 |
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SHE:000766 |
$2.21 Billion | CN¥15.11 Billion | China | CN¥15.63 | -2.62% | -5.10% | 364.59 Million |
| 100 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
$2.12 Billion | $2.12 Billion | USA | $21.64 | +0.05% | +0.28% | 72.66 Million |
| 101 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX |
$2.09 Billion | $2.09 Billion | USA | $8.23 | +1.35% | -18.43% | 84.73 Million |
| 102 |
Jiangzhong Pharmaceutical Co Ltd
SHG:600750 |
$2.08 Billion | CN¥14.19 Billion | China | CN¥22.33 | +0.00% | -4.74% | 115.45 Million |
| 103 |
Shilpa Medicare Limited
NSE:SHILPAMED |
$2.03 Billion | Rs187.98 Billion | India | Rs961.15 | +2.26% | +0.59% | 31.35 Million |
| 104 |
Eris Lifesciences Limited
NSE:ERIS |
$2.03 Billion | Rs187.85 Billion | India | Rs1355.50 | -0.08% | +3.99% | 1.82 Million |
| 105 |
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
$2.02 Billion | CN¥13.83 Billion | China | CN¥86.82 | +0.28% | -3.26% | 109.83 Million |
| 106 |
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
$2.00 Billion | CN¥13.68 Billion | China | CN¥11.41 | +2.52% | -1.98% | 972.69 Million |
| 107 |
Dermapharm Holding SE
XETRA:DMP |
$1.97 Billion | €1.68 Billion | Germany | €37.90 | +1.34% | -4.29% | 1.19 Million |
| 108 |
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601 |
$1.95 Billion | CN¥13.30 Billion | China | CN¥11.91 | +1.36% | -5.33% | 690.24 Million |
| 109 |
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
$1.94 Billion | CN¥13.24 Billion | China | CN¥15.02 | +3.66% | -0.33% | 697.79 Million |
| 110 |
Guobang Pharma Ltd
SHG:605507 |
$1.85 Billion | CN¥12.61 Billion | China | CN¥16.12 | +2.74% | +3.47% | 115.73 Million |
| 111 |
HUTCHMED (China) Limited
F:H7T1 |
$1.84 Billion | €1.57 Billion | Germany | €11.30 | +2.73% | -6.61% | 0.00 |
| 112 |
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SHG:603707 |
$1.77 Billion | CN¥12.09 Billion | China | CN¥7.48 | +0.67% | -5.20% | 329.04 Million |
| 113 |
Zhejiang Medicine Co Ltd
SHG:600216 |
$1.77 Billion | CN¥12.07 Billion | China | CN¥12.55 | +1.78% | -1.03% | 861.45 Million |
| 114 |
Wedge Industrial Co Ltd
SHE:000534 |
$1.76 Billion | CN¥12.05 Billion | China | CN¥23.64 | -1.58% | -5.14% | 369.33 Million |
| 115 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
$1.76 Billion | $1.76 Billion | USA | $15.50 | +0.00% | +0.10% | 76.22 Million |
| 116 |
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
$1.76 Billion | Rs162.38 Billion | India | Rs1025.20 | -0.04% | +12.92% | 10.07 Million |
| 117 |
Shenzhen Hepalink Pharmaceutical Co Ltd
SHE:002399 |
$1.75 Billion | CN¥11.99 Billion | China | CN¥9.61 | +1.37% | -2.24% | 176.60 Million |
| 118 |
Alembic Pharmaceuticals Limited
NSE:APLLTD |
$1.72 Billion | Rs159.40 Billion | India | Rs810.95 | -0.67% | +0.91% | 2.78 Million |
| 119 |
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
$1.72 Billion | CN¥11.75 Billion | China | CN¥36.46 | -2.27% | -4.19% | 118.24 Million |
| 120 |
Porton Fine Chemicals Ltd
SHE:300363 |
$1.71 Billion | CN¥11.67 Billion | China | CN¥21.47 | +5.04% | +9.15% | 761.25 Million |
| 121 |
Hanall Biopharma
KO:009420 |
$1.70 Billion | ₩2.50 Trillion | Korea | ₩49300.00 | -1.60% | -9.87% | 8.02 Million |
| 122 |
Eton Pharmaceuticals Inc
NASDAQ:ETON |
$1.65 Billion | $1.65 Billion | USA | $57.62 | +0.95% | -3.81% | 15.26 Million |
| 123 |
Shanghai Shyndec Pharmaceutical Co Ltd
SHG:600420 |
$1.63 Billion | CN¥11.16 Billion | China | CN¥8.32 | +0.36% | -2.00% | 204.30 Million |
| 124 |
Perrigo Company PLC
NYSE:PRGO |
$1.62 Billion | $1.62 Billion | USA | $13.65 | -0.07% | -4.34% | 57.27 Million |
| 125 |
BORA PHARMACEUTICALS LTD
TW:6472 |
$1.62 Billion | NT$51.36 Billion | Taiwan | NT$403.50 | +1.13% | -3.00% | 25.02 Million |
| 126 |
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572 |
$1.60 Billion | CN¥10.97 Billion | China | CN¥4.32 | +2.37% | -1.59% | 2.31 Billion |
| 127 |
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285 |
$1.59 Billion | CN¥10.87 Billion | China | CN¥19.16 | +0.68% | -2.29% | 268.77 Million |
| 128 |
Natco Pharma Limited
NSE:NATCOPHARM |
$1.58 Billion | Rs146.04 Billion | India | Rs815.35 | -0.40% | -2.74% | 12.00 Million |
| 129 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
$1.58 Billion | $1.58 Billion | USA | $70.40 | +0.30% | -2.21% | 8.44 Million |
| 130 |
Fagron NV
BR:FAGR |
$1.55 Billion | €1.33 Billion | Belgium | €21.15 | +0.71% | -2.31% | 1.89 Million |
| 131 |
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
$1.55 Billion | CN¥10.58 Billion | China | CN¥11.40 | +2.52% | -2.56% | 332.90 Million |
| 132 |
PharmaBlock Sciences Nanjing Inc Class A
SHE:300725 |
$1.52 Billion | CN¥10.42 Billion | China | CN¥44.55 | +8.34% | +4.26% | 567.46 Million |
| 133 |
Yantai Dongcheng Pharmaceutical Co Ltd
SHE:002675 |
$1.52 Billion | CN¥10.41 Billion | China | CN¥12.62 | +1.53% | -0.94% | 169.53 Million |
| 134 |
Lotus Pharmaceutical Co Ltd
TW:1795 |
$1.45 Billion | NT$46.17 Billion | Taiwan | NT$173.50 | +0.00% | -4.67% | 25.64 Million |
| 135 |
Zhejiang Jingxin Pharmaceutical Co Ltd
SHE:002020 |
$1.45 Billion | CN¥9.91 Billion | China | CN¥11.51 | +1.86% | -9.23% | 365.77 Million |
| 136 |
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
$1.45 Billion | CN¥9.90 Billion | China | CN¥24.27 | +2.49% | -3.61% | 273.89 Million |
| 137 |
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
$1.43 Billion | CN¥9.76 Billion | China | CN¥3.25 | +1.56% | -1.52% | 1.94 Billion |
| 138 |
Mayinglong Pharmaceutical Group Co Ltd
SHG:600993 |
$1.42 Billion | CN¥9.72 Billion | China | CN¥22.55 | +1.90% | -2.21% | 104.30 Million |
| 139 |
Faes Farma SA
MC:FAE |
$1.40 Billion | €1.19 Billion | Spain | €4.46 | +0.00% | -1.33% | 1.93 Million |
| 140 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
$1.38 Billion | $1.38 Billion | USA | $7.57 | +1.61% | -11.87% | 37.93 Million |
| 141 |
H Lundbeck A/S
CO:HLUN-A |
$1.37 Billion | Dkr8.74 Billion | Denmark | Dkr43.90 | +0.23% | +0.11% | 5.02 Million |
| 142 |
CONSUN PHARMAC.GR.HD -10
F:C1P |
$1.35 Billion | €1.15 Billion | Germany | €1.41 | +2.92% | -2.08% | 700.00 |
| 143 |
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099 |
$1.34 Billion | CN¥9.15 Billion | China | CN¥5.65 | +6.81% | +4.44% | 526.58 Million |
| 144 |
Akums Drugs and Pharmaceutical
NSE:AKUMS |
$1.29 Billion | Rs118.86 Billion | India | Rs776.35 | +3.56% | -0.54% | 9.26 Million |
| 145 |
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
$1.28 Billion | CN¥8.77 Billion | China | CN¥25.81 | +1.53% | -5.53% | 1.24 Billion |
| 146 |
Perrigo Company plc
F:PIG |
$1.28 Billion | €1.10 Billion | Germany | €12.02 | +3.58% | -2.75% | 350.00 |
| 147 |
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263 |
$1.28 Billion | CN¥8.73 Billion | China | CN¥20.52 | +3.90% | +4.69% | 111.07 Million |
| 148 |
Harrow Health Inc
NASDAQ:HROW |
$1.28 Billion | $1.28 Billion | USA | $34.07 | -1.19% | -10.95% | 13.51 Million |
| 149 |
Teva Pharmaceutical Industries Ltd
TA:TEVA |
$1.28 Billion | ILA475.95 Billion | Israel | ILA11540.00 | +3.78% | +4.91% | 21.33 Million |
| 150 |
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
$1.26 Billion | CN¥8.59 Billion | China | CN¥8.68 | +1.64% | +0.00% | 357.20 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - Specialty & Generic industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - specialty & generic corporations. View all industries